Mann KG, Kalafatis M, Factor V (2003) A combination of Dr Jekyll and Mr Hyde. Blood 101(1):20–30. https://doi.org/10.1182/blood-2002-01-0290

Article  CAS  PubMed  Google Scholar 

Nicolaes GA, Dahlbäck B (2002) Factor V and thrombotic disease: description of a janus-faced protein. Arterioscler Thromb Vasc Biol 22(4):530–538. https://doi.org/10.1161/01.atv.0000012665.51263.b7

Article  CAS  PubMed  Google Scholar 

Duga S, Asselta R, Tenchini ML (2004) Coagulation factor V. Int J Biochem Cell Biol 36(8):1393–1399. https://doi.org/10.1016/j.biocel.2003.08.002

Article  CAS  PubMed  Google Scholar 

Ahnström J (2021) FV/FVa revealed. Blood 137(22):3011–3013. https://doi.org/10.1182/blood.2021011573

Article  CAS  PubMed  Google Scholar 

Dahlbäck B (2017) Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S. J Thromb Haemost 15(7):1241–1250. https://doi.org/10.1111/jth.13665

Article  CAS  PubMed  Google Scholar 

Cramer TJ, Gale AJ (2012) The anticoagulant function of coagulation factor V. Thromb Haemost 107(1):15–21. https://doi.org/10.1160/TH11-06-0431

Article  CAS  PubMed  Google Scholar 

Bertina RM, Koeleman BP, Koster T (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369(6475):64–67. https://doi.org/10.1038/369064a0

Article  CAS  PubMed  Google Scholar 

Kujovich JL (2011) Factor V Leiden thrombophilia. Genet Med 13(1):1–16. https://doi.org/10.1097/GIM.0b013e3181faa0f2

Article  CAS  PubMed  Google Scholar 

Chan WP, Lee CK, Kwong YL, Lam CK, Liang R (1998) A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91(4):1135–1139

Article  CAS  PubMed  Google Scholar 

Williamson D, Brown K, Luddington R, Factor V (1998) Cambridge: a new mutation (Arg306–>Thr) associated with resistance to activated protein C. Blood 91(4):1140–1144

Article  CAS  PubMed  Google Scholar 

Norstrøm E, Thorelli E, Dahlbäck B (2002) Functional characterization of Recombinant FV Hong Kong and FV Cambridge. Blood 100(2):524–530. https://doi.org/10.1182/blood-2002-02-0343

Article  CAS  PubMed  Google Scholar 

Liang R, Lee CK, Wat MS (1998) Clinical significance of Arg306 mutations of factor V gene. Blood 92(7):2599–2600

Article  CAS  PubMed  Google Scholar 

Song KS, Park YS, Kim HK (1998) Prevalence of Arg306 mutation of the factor V gene in Korean patients with thrombosis. Haemostasis 28(5):276. https://doi.org/10.1159/000022443

Article  CAS  PubMed  Google Scholar 

Franco RF, Maffei FH, Lourenço D, Factor V (1998) Arg306–>Thr (factor V Cambridge) and factor V Arg306–>Gly mutations in venous thrombotic disease. Br J Haematol 103(3):888–890. https://doi.org/10.1046/j.1365-2141.1998.01051.x

Article  CAS  PubMed  Google Scholar 

Franco RF, Elion J, Tavella MH (1999) The prevalence of factor V Arg306–>Thr (factor V Cambridge) and factor V Arg306–>Gly mutations in different human populations. Thromb Haemost 81(2):312–313

Article  CAS  PubMed  Google Scholar 

Hiyoshi M, Hashimoto S, Tagawa S (1999) A Thai patient with the mutation of Arg306 of FV gene identical to the Hong Kong but not to the Cambridge type. Thromb Haemost 82(5):1553–1554

CAS  PubMed  Google Scholar 

Shen MC, Lin JS, Tsay W, Factor V (2001) Arg306 Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese. Thromb Haemost 85(2):270–273

Article  CAS  PubMed  Google Scholar 

Ding Q, Shen W, Ye X (2013) Clinical and genetic features of protein C deficiency in 23 unrelated Chinese patients. Blood Cells Mol Dis 50(1):53–58. https://doi.org/10.1016/j.bcmd.2012.08.004

Article  CAS  PubMed  Google Scholar 

Wu Y, Liu J, Zeng W, Protein S (2022) Deficiency and the risk of venous thromboembolism in the Han Chinese population. Front Cardiovasc Med 8:796755. https://doi.org/10.3389/fcvm.2021.796755

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou YB, Liu J, Song L (2019) Interpretation of guideline for the genetic diagnosis of Monogenic cardiovascular diseases. Chin J Cardio 47(3):175–196. https://CNKI:SUN:ZGFB.0.2019-02-001

Dirven RJ, Vos HL, Bertina RM (2010) The R306G and R506Q mutations in coagulation factor V reveals additional cleavage sites for activated protein C in the R313-R321 region and at R505. Thromb Res 125(5):444–450. https://doi.org/10.1016/j.thromres.2009.12.005

Article  CAS  PubMed  Google Scholar 

Tran S, Dahlbäck B (2010) Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S. J Thromb Haemost 8(1):129–136. https://doi.org/10.1111/j.1538-7836.2009.03657.x

Article  CAS  PubMed  Google Scholar 

Thorelli E, Kaufman RJ, Dahlbäck B (1999) Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood 93(8):2552–2558

Article  CAS  PubMed  Google Scholar 

Su K, Wang L, Wang M (2021) A novel mutation (Ser951LeufsTer8) in F5 gene leads to hereditary coagulation factor V deficiency. Blood Coagul Fibrinolysis 32(2):140–145. https://doi.org/10.1097/MBC.0000000000001003

Article  CAS  PubMed  Google Scholar 

Rees DC, Cox M, Clegg JB (1995) World distribution of factor V Leiden. Lancet 346(8983):1133–1134. https://doi.org/10.1016/s0140-6736(95)91803-5

Article  CAS  PubMed  Google Scholar 

Bernardi F, Faioni EM, Castoldi E (1997) A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 90(4):1552–1557

Article  CAS  PubMed  Google Scholar 

Castoldi E (2014) FV and APC resistance: the plot thickens. Blood 123(15):2288–2289. https://doi.org/10.1182/blood-2014-02-557363

Article  CAS  PubMed  Google Scholar 

Le Cam-Duchez V, Chrétien MH, Saugier-Veber P (2006) Factor V Cambridge mutation and activated protein C resistance assays. Thromb Haemost 95(3):581–583. https://doi.org/10.1160/TH05-11-0740

Article  CAS  PubMed  Google Scholar 

Joly B, Menard AL, Ozkul-Wermester O (2014) Involvement of Arg306 mutation in factor V gene in two young men with ischemic stroke. Blood Coagul Fibrinolysis 25(8):916–917. https://doi.org/10.1097/MBC.0000000000000165

Article  PubMed  Google Scholar 

van der Neut Kolfschoten M, Dirven RJ, Vos HL (2004) Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679. J Biol Chem 279(8):6567–6575. https://doi.org/10.1074/jbc.M308574200

Article  CAS  PubMed  Google Scholar 

de la Morena-Barrio ME, Suchon P, Jacobsen EM (2022) Two SERPINC1 variants affecting N-glycosylation of Asn224 ca